Ironwood Pharmaceuticals, A Buy At $12
May 24, 2013 8:34 PM | about stocks: IRWD
May 2013.I recommend Ironwood (IRWD) a Buy at $12.00. The company's new drug is growing revenue and acceptance in the marketplace.
Factors:
1) Good Management
2) Inside Ownership
3) Leader in Field
4) Favorable Risk/Reward
6) Competitive Edge
7) Strong Product Offering
Disclosure: I am long IRWD.
Stocks: IRWD